Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

O'Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad NS, Ueno M, Chui SY, Zhang Y, Patel H, Lee Y, Salman Z, Wolpin BM, RASolute 302 Trial Investigators.

Open source

DOI: 10.1056/nejmoa2605555
Published: 2026-05-31
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2605555,
  title = {Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.},
  author = {O'Reilly EM and  Wainberg ZA and  Hendifar AE and  Borad MJ and  Pietrantonio F and  Pant S and  Hammel P and  Cremolini C and  Manji GA and  Oberstein PE and  Garrido-Laguna I and  Springfeld C and  Azad NS and  Ueno M and  Chui SY and  Zhang Y and  Patel H and  Lee Y and  Salman Z and  Wolpin BM and  RASolute 302 Trial Investigators.},
  year = {2026},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2605555},
  url = {https://doi.org/10.1056/nejmoa2605555}
}

RIS

TY  - JOUR
TI  - Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
AU  - O'Reilly EM
AU  -  Wainberg ZA
AU  -  Hendifar AE
AU  -  Borad MJ
AU  -  Pietrantonio F
AU  -  Pant S
AU  -  Hammel P
AU  -  Cremolini C
AU  -  Manji GA
AU  -  Oberstein PE
AU  -  Garrido-Laguna I
AU  -  Springfeld C
AU  -  Azad NS
AU  -  Ueno M
AU  -  Chui SY
AU  -  Zhang Y
AU  -  Patel H
AU  -  Lee Y
AU  -  Salman Z
AU  -  Wolpin BM
AU  -  RASolute 302 Trial Investigators.
PY  - 2026
JO  - N Engl J Med
DO  - 10.1056/nejmoa2605555
UR  - https://doi.org/10.1056/nejmoa2605555
ER  -

APA

EM, O., ZA, W., AE, H., MJ, B., F, P., S, P., P, H., C, C., GA, M., PE, O., I, G., C, S., NS, A., M, U., SY, C., Y, Z., H, P., Y, L., Z, S., BM, W., & Investigators., R. 3. T. (2026). Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.. N Engl J Med. https://doi.org/10.1056/nejmoa2605555

Source records

europe-pmc · retrieved 2026-09-27T03:07:38.149Z